맞춤형 의료 바이오마커 시장 규모, 점유율, 동향, 산업 분석 보고서 : 적응증별, 용도별, 지역별 - 시장 예측(2025-2034년)

The personalized medicine biomarkers market size is expected to reach USD 78.27 billion by 2034, according to a new study by Polaris Market Research. The report "Personalized Medicine Biomarkers Market Size, Share, Trends, Industry Analysis Report: By Indication, Application (Early Detection/Screening, Diagnosis, Treatment Selection, and Monitoring), and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa); Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The personalized medicine biomarkers market is rapidly growing due to the rising demand for targeted therapies and precision medicine. Biomarkers are biological indicators used to predict disease risk, diagnose conditions, and monitor treatment response. Biomarker applications are across critical areas such as oncology, neurology, cardiology, and autoimmune diseases, where personalized approaches significantly enhance patient outcomes.

Market growth is propelled by advancements in biomarker technologies, including genomic and proteomic innovations, which enable the development of precise diagnostic and therapeutic solutions. The increasing prevalence of chronic conditions such as cancer, diabetes, and cardiovascular diseases further amplifies the demand for biomarkers, contributing to market growth such as early detection, treatment selection, and monitoring.

Strategic partnerships between pharmaceutical companies, diagnostic firms, and research organizations are accelerating biomarker development and adoption, creating significant personalized medicine biomarkers market opportunities. Furthermore, the aging population is more prone to chronic and age-related conditions, creating a higher demand for biomarkers to personalize treatments for this demographic.

Personalized Medicine Biomarkers Market Report Highlights

In terms of application, in 2024, the treatment selection segment accounted for the largest share of the market due to the growing demand for precision therapies tailored to individual patient profiles.

The diabetes segment, based on indication, is expected to witness the highest CAGR over the forecast period due to the rising global prevalence of diabetes.

In 2024, North America dominated the personalized medicine biomarkers market due to due to significant investments in research and development.

The Asia Pacific market is expected to witness significant growth over the forecast period due to the rising prevalence of chronic diseases.

A few global key market players include Laboratory Corporation of America Holding; Quest Diagnostics Incorporated; Agilent Technologies, Inc.; Genome Medical, Inc.; Coriell Life Sciences; Thermo Fisher Scientific Inc.; NeoGenomics Laboratories; FOUNDATION MEDICINE, INC.; Illumina, Inc.; Guardant Health.

Polaris Market Research has segmented the personalized medicine biomarkers market report on the indication, application, and region:

By Indication Outlook (Revenue, USD Billion; 2020-2034)

• Oncology
• By Type
• § Breast Cancer
• § Lung Cancer
• § Colon Cancer
• § Others
• By Circulating Biomarkers
• § Circulating Tumor Cells(CTCs)
• § Circulating Cell-free DNA(cfDNA)
• § Extracellular Vesicles (EVs)
• § Other Circulating Biomarkers
• Neurology
• Diabetes
• Autoimmune Diseases
• Cardiology
• Others

By Application Outlook (Revenue, USD Billion; 2020-2034)

• Early Detection/Screening
• Diagnosis
• Treatment Selection
• Monitoring

By Regional Outlook (Revenue, USD Billion; 2020-2034)

• North America
• US
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• Russia
• Netherlands
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Malaysia
• Vietnam
• Australia
• Rest of Asia Pacific
• Latin America
• Argentina
• Brazil
• Mexico
• Rest of Latin America
• Middle East & Africa
• UAE
• Saudi Arabia
• Israel
• South Africa
• Rest of Middle East & Africa

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions
• 1.2. Stakeholders

2. Executive Summary

• 2.1. Market Highlights

3. Research Methodology

• 3.1. Overview
  • 3.1.1. Data Mining
• 3.2. Data Sources
  • 3.2.1. Primary Sources
  • 3.2.2. Secondary Sources

4. Global Personalized Medicine Biomarkers Market Insights

• 4.1. Personalized Medicine Biomarkers Market - Market Snapshot
• 4.2. Personalized Medicine Biomarkers Market Dynamics
  • 4.2.1. Drivers and Opportunities
    • 4.2.1.1. Rising Prevalence of Chronic Diseases
    • 4.2.1.2. Rising Collaboration Between Pharmaceutical and Diagnostics Companies
  • 4.2.2. Restraints and Challenges
    • 4.2.2.1. High Development Costs
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers (Moderate)
  • 4.3.2. Threats of New Entrants: (Low)
  • 4.3.3. Bargaining Power of Buyers (Moderate)
  • 4.3.4. Threat of Substitute (Moderate)
  • 4.3.5. Rivalry among existing firms (High)
• 4.4. PESTEL Analysis
• 4.5. Personalized Medicine Biomarkers Market Application Trends
• 4.6. Value Chain Analysis
• 4.7. COVID-19 Impact Analysis

5. Global Personalized Medicine Biomarkers Market, by Indication

• 5.1. Key Findings
• 5.2. Introduction
  • 5.2.1. Global Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
• 5.3. Oncology
  • 5.3.1. Global Personalized Medicine Biomarkers Market, by Oncology, by Region, 2020-2034 (USD Billion)
  • 5.3.2. Type
    • 5.3.2.1. Global Personalized Medicine Biomarkers Market, by Type, by Region, 2020-2034 (USD Billion)
    • 5.3.2.2. Breast Cancer
    • 5.3.2.2.1. Global Personalized Medicine Biomarkers Market, by Breast Cancer, by Region, 2020-2034 (USD Billion)
    • 5.3.2.3. Lung Cancer
    • 5.3.2.3.1. Global Personalized Medicine Biomarkers Market, by Lung Cancer, by Region, 2020-2034 (USD Billion)
    • 5.3.2.4. Colon Cancer
    • 5.3.2.4.1. Global Personalized Medicine Biomarkers Market, by Colon Cancer, by Region, 2020-2034 (USD Billion)
    • 5.3.2.5. Others
    • 5.3.2.5.1. Global Personalized Medicine Biomarkers Market, by Others, by Region, 2020-2034 (USD Billion)
  • 5.3.3. Circulating Biomarkers
    • 5.3.3.1. Global Personalized Medicine Biomarkers Market, by Circulating Biomarkers, by Region, 2020-2034 (USD Billion)
    • 5.3.3.2. Circulating Tumor Cells(CTCs)
    • 5.3.3.2.1. Global Personalized Medicine Biomarkers Market, by Circulating Tumor Cells(CTCs), by Region, 2020-2034 (USD Billion)
    • 5.3.3.3. Circulating Cell-free DNA(cfDNA)
    • 5.3.3.3.1. Global Personalized Medicine Biomarkers Market, by Circulating Cell-free DNA(cfDNA), by Region, 2020-2034 (USD Billion)
    • 5.3.3.4. Extracellular Vesicles (EVs)
    • 5.3.3.4.1. Global Personalized Medicine Biomarkers Market, by Extracellular Vesicles (EVs), by Region, 2020-2034 (USD Billion)
    • 5.3.3.5. Other Circulating Biomarkers
    • 5.3.3.5.1. Global Personalized Medicine Biomarkers Market, by Other Circulating Biomarkers, by Region, 2020-2034 (USD Billion)
• 5.4. Neurology
  • 5.4.1. Global Personalized Medicine Biomarkers Market, by Neurology, by Region, 2020-2034 (USD Billion)
• 5.5. Diabetes
  • 5.5.1. Global Personalized Medicine Biomarkers Market, by Diabetes, by Region, 2020-2034 (USD Billion)
• 5.6. Autoimmune Diseases
  • 5.6.1. Global Personalized Medicine Biomarkers Market, by Autoimmune Diseases, by Region, 2020-2034 (USD Billion)
• 5.7. Cardiology
  • 5.7.1. Global Personalized Medicine Biomarkers Market, by Cardiology, by Region, 2020-2034 (USD Billion)
• 5.8. Others
  • 5.8.1. Global Personalized Medicine Biomarkers Market, by Others, by Region, 2020-2034 (USD Billion)

6. Global Personalized Medicine Biomarkers Market, by Application

• 6.1. Key Findings
• 6.2. Introduction
  • 6.2.1. Global Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
• 6.3. Early Detection/Screening
  • 6.3.1. Global Personalized Medicine Biomarkers Market, by Early Detection/Screening, by Region, 2020-2034 (USD Billion)
• 6.4. Diagnosis
  • 6.4.1. Global Personalized Medicine Biomarkers Market, by Diagnosis, by Region, 2020-2034 (USD Billion)
• 6.5. Treatment Selection
  • 6.5.1. Global Personalized Medicine Biomarkers Market, by Treatment Selection, by Region, 2020-2034 (USD Billion)
• 6.6. Monitoring
  • 6.6.1. Global Personalized Medicine Biomarkers Market, by Monitoring, by Region, 2020-2034 (USD Billion)

7. Global Personalized Medicine Biomarkers Market, by Geography

• 7.1. Key Findings
• 7.2. Introduction
  • 7.2.1. Personalized Medicine Biomarkers Market Assessment, By Geography, 2020-2034 (USD Billion)
• 7.3. Personalized Medicine Biomarkers Market - North America
  • 7.3.1. North America: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
  • 7.3.2. North America: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 7.3.3. Personalized Medicine Biomarkers Market - US
    • 7.3.3.1. US: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
    • 7.3.3.2. US: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 7.3.4. Personalized Medicine Biomarkers Market - Canada
    • 7.3.4.1. Canada: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
    • 7.3.4.2. Canada: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
• 7.4. Personalized Medicine Biomarkers Market - Europe
  • 7.4.1. Europe: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
  • 7.4.2. Europe: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 7.4.3. Personalized Medicine Biomarkers Market - UK
    • 7.4.3.1. UK: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
    • 7.4.3.2. UK: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 7.4.4. Personalized Medicine Biomarkers Market - France
    • 7.4.4.1. France: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
    • 7.4.4.2. France: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 7.4.5. Personalized Medicine Biomarkers Market - Germany
    • 7.4.5.1. Germany: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
    • 7.4.5.2. Germany: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 7.4.6. Personalized Medicine Biomarkers Market - Italy
    • 7.4.6.1. Italy: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
    • 7.4.6.2. Italy: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 7.4.7. Personalized Medicine Biomarkers Market - Spain
    • 7.4.7.1. Spain: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
    • 7.4.7.2. Spain: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 7.4.8. Personalized Medicine Biomarkers Market - Netherlands
    • 7.4.8.1. Netherlands: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
    • 7.4.8.2. Netherlands: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 7.4.9. Personalized Medicine Biomarkers Market - Russia
    • 7.4.9.1. Russia: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
    • 7.4.9.2. Russia: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 7.4.10. Personalized Medicine Biomarkers Market - Rest of Europe
    • 7.4.10.1. Rest of Europe: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
    • 7.4.10.2. Rest of Europe: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
• 7.5. Personalized Medicine Biomarkers Market - Asia Pacific
  • 7.5.1. Asia Pacific: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
  • 7.5.2. Asia Pacific: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 7.5.3. Personalized Medicine Biomarkers Market - China
    • 7.5.3.1. China: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
    • 7.5.3.2. China: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 7.5.4. Personalized Medicine Biomarkers Market - India
    • 7.5.4.1. India: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
    • 7.5.4.2. India: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 7.5.5. Personalized Medicine Biomarkers Market - Malaysia
    • 7.5.5.1. Malaysia: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
    • 7.5.5.2. Malaysia: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 7.5.6. Personalized Medicine Biomarkers Market - Japan
    • 7.5.6.1. Japan: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
    • 7.5.6.2. Japan: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 7.5.7. Personalized Medicine Biomarkers Market - Indonesia
    • 7.5.7.1. Indonesia: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
    • 7.5.7.2. Indonesia: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 7.5.8. Personalized Medicine Biomarkers Market - South Korea
    • 7.5.8.1. South Korea: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
    • 7.5.8.2. South Korea: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 7.5.9. Personalized Medicine Biomarkers Market - Australia
    • 7.5.9.1. Australia: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
    • 7.5.9.2. Australia: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 7.5.10. Personalized Medicine Biomarkers Market - Rest of Asia Pacific
    • 7.5.10.1. Rest of Asia Pacific: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
    • 7.5.10.2. Rest of Asia Pacific: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
• 7.6. Personalized Medicine Biomarkers Market - Middle East & Africa
  • 7.6.1. Middle East & Africa: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
  • 7.6.2. Middle East & Africa: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 7.6.3. Personalized Medicine Biomarkers Market - Saudi Arabia
    • 7.6.3.1. Saudi Arabia: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
    • 7.6.3.2. Saudi Arabia: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 7.6.4. Personalized Medicine Biomarkers Market - UAE
    • 7.6.4.1. UAE: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
    • 7.6.4.2. UAE: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 7.6.5. Personalized Medicine Biomarkers Market - Israel
    • 7.6.5.1. Israel: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
    • 7.6.5.2. Israel: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 7.6.6. Personalized Medicine Biomarkers Market - South Africa
    • 7.6.6.1. South Africa: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
    • 7.6.6.2. South Africa: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 7.6.7. Personalized Medicine Biomarkers Market - Rest of Middle East & Africa
    • 7.6.7.1. Rest of Middle East & Africa: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
    • 7.6.7.2. Rest of Middle East & Africa: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
• 7.7. Personalized Medicine Biomarkers Market - Latin America
  • 7.7.1. Latin America: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
  • 7.7.2. Latin America: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 7.7.3. Personalized Medicine Biomarkers Market - Mexico
    • 7.7.3.1. Mexico: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
    • 7.7.3.2. Mexico: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 7.7.4. Personalized Medicine Biomarkers Market - Brazil
    • 7.7.4.1. Brazil: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
    • 7.7.4.2. Brazil: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 7.7.5. Personalized Medicine Biomarkers Market - Argentina
    • 7.7.5.1. Argentina: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
    • 7.7.5.2. Argentina: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 7.7.6. Personalized Medicine Biomarkers Market - Rest of Latin America
    • 7.7.6.1. Rest of Latin America: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
    • 7.7.6.2. Rest of Latin America: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

8. Competitive Landscape

• 8.1. Expansion and Acquisition Analysis
  • 8.1.1. Expansion
  • 8.1.2. Acquisitions
• 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

• 9.1. Laboratory Corporation of America Holding
  • 9.1.1. Company Overview
  • 9.1.2. Financial Performance
  • 9.1.3. Product Benchmarking
  • 9.1.4. Recent Development
• 9.2. Quest Diagnostics Incorporated
  • 9.2.1. Company Overview
  • 9.2.2. Financial Performance
  • 9.2.3. Product Benchmarking
  • 9.2.4. Recent Development
• 9.3. Agilent Technologies, Inc.
  • 9.3.1. Company Overview
  • 9.3.2. Financial Performance
  • 9.3.3. Product Benchmarking
  • 9.3.4. Recent Development
• 9.4. Genome Medical, Inc.
  • 9.4.1. Company Overview
  • 9.4.2. Financial Performance
  • 9.4.3. Product Benchmarking
  • 9.4.4. Recent Development
• 9.5. Coriell Life Sciences.
  • 9.5.1. Company Overview
  • 9.5.2. Financial Performance
  • 9.5.3. Product Benchmarking
  • 9.5.4. Recent Development
• 9.6. Thermo Fisher Scientific Inc.
  • 9.6.1. Company Overview
  • 9.6.2. Financial Performance
  • 9.6.3. Product Benchmarking
  • 9.6.4. Recent Development
• 9.7. NeoGenomics Laboratories
  • 9.7.1. Company Overview
  • 9.7.2. Financial Performance
  • 9.7.3. Product Benchmarking
  • 9.7.4. Recent Development
• 9.8. FOUNDATION MEDICINE, INC.
  • 9.8.1. Company Overview
  • 9.8.2. Financial Performance
  • 9.8.3. Product Benchmarking
  • 9.8.4. Recent Development
• 9.9. Illumina, Inc.
  • 9.9.1. Company Overview
  • 9.9.2. Financial Performance
  • 9.9.3. Product Benchmarking
  • 9.9.4. Recent Development
• 9.10. Guardant Health
  • 9.10.1. Company Overview
  • 9.10.2. Financial Performance
  • 9.10.3. Product Benchmarking
  • 9.10.4. Recent Development